secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silence Therapeutics plc (SLN)
CIK:        0001479615
Form:       8-K
Filed at:   2026-06-16T21:00:17+00:00
Accession:  0001193125-26-272814
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

All 9 resolutions pass at Silence Therapeutics 2026 AGM including director re-elections and say-on-pay
--------------------------------------------------------------------------------

- Both director nominees re-elected: Rhonda Hellums (47.2M for, 5.6M against) and James Ede-Golightly (52.1M for, 0.6M against).
- Advisory say-on-pay approved with 48.2M votes for, 73.7K against, and 4.4M abstentions.
- Ratification of PricewaterhouseCoopers as US and UK auditors passed with ~52.7M votes for.
- Directors' remuneration report for 2025 approved: 48.3M for, 66.5K against, 4.4M abstentions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479615/000119312526272814/0001193125-26-272814-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479615/000119312526272814/sln-20260616.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-272814

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer